Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies
- 1 November 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 175 (9) , 5586-5590
Abstract
TNF apoptosis-inducing ligand is attracting considerable interest as a potential extrinsic tumor suppressor mechanism, although previous reports have conveyed somewhat contrasting views regarding the likely importance of this pathway. In this study, we provide the first evaluation of spontaneous tumor formation over the life span of TRAIL-deficient mice. Interestingly, >25% of these mice do develop lymphoid malignancies after 500 days of life. TRAIL suppressed the initiation and development of both tumors of lymphoid and stromal origin in the context of the loss of at least one p53 allele. Specific examination of the role of TRAIL in Her2/neu oncogene-driven mammary epithelial cancer revealed no critical role for TRAIL despite the inherent TRAIL sensitivity of such mammary carcinomas. Overall, the data indicate an important function of TRAIL in controlling carcinogenesis, but suggest that further examination of this pathway in epithelial malignancies is warranted.Keywords
This publication has 23 references indexed in Scilit:
- CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell deathNature, 2005
- MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional cultureJournal of Experimental Medicine, 2005
- Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant miceCell Death & Differentiation, 2004
- Tumor Necrosis Factor-Related Apoptosis-Inducing LigandCancer Research, 2004
- Nature's TRAIL—On a Path to Cancer ImmunotherapyImmunity, 2003
- T cells require TRAIL for optimal graft-versus-tumor activityNature Medicine, 2002
- Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γJournal of Experimental Medicine, 2002
- Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor DevelopmentJournal of Experimental Medicine, 2002
- Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAILJournal of Experimental Medicine, 1999
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992